Showing results (31-40 of 249) with videos related to

Sort By:
Pageof 25
Current Opinion in Investigational Drugs (London, England : 2000)|May 30, 2006
Autophagy: A protective mechanism in response to stress and inflammationDominique Heymann
Journal of Bone Oncology|February 25, 2016
Anti-RANKL therapy for bone tumours: Basic, pre-clinical and clinical evidencesDominique Heymann
Cancer Research|September 16, 2010
Zoledronic acid as a new adjuvant therapeutic strategy for Ewing's sarcoma patientsGuillaume A Odri, Sophie Dumoucel, Gaëlle Picarda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 10, 2014
Overexpression of smad7 blocks primary tumor growth and lung metastasis development in osteosarcomaAudrey Lamora, Julie Talbot, Gwenola Bougras, et al.
Bioconjugate Chemistry|May 3, 2019
12b80 - Hydroxybisphosphonate Linked Doxorubicin: Bone Targeted Strategy for Treatment of OsteosarcomaEmmanuelle David, Sébastien Cagnol, Jean-Yves Goujon, et al.
Bonekey Reports|January 15, 2014
Targeted therapies for bone sarcomasDominique Heymann, Françoise Rédini
Expert Review of Clinical Pharmacology|January 6, 2012
Pharmacodynamics of bisphosphonates in arthritisBenoit Le Goff, Dominique Heymann
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Exosomal lncRNAs: the newest promising liquid biopsyMarta Tellez-Gabriel, Dominique Heymann
Expert Review of Anticancer Therapy|February 10, 2007
Recent advances in the management of osteosarcoma and forthcoming therapeutic strategiesFrançois Lamoureux, Valérie Trichet, Céline Chipoy, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 19, 2012
Modulatory effects of proteoglycans on proteinase activitiesSteven Georges, Dominique Heymann, Marc Padrines
Pageof 25